Areas of Focus
- Radiobiology
- Lung cancer radiotherapy resistance mechanisms
Work Experience
- 2012-2015: Resident Physician, Oncology Center, Renmin Hospital of Wuhan University
- 2015-2018: Attending Physician, Oncology Center, Renmin Hospital of Wuhan University
- 2018-present: Deputy Chief Physician, Oncology Center, Renmin Hospital of Wuhan University
Academic Background & Achievements
- 2005-2012: MD and Master's in Clinical Medicine, Wuhan University
- 2013-2016: PhD in Otorhinolaryngology Head and Neck Surgery, Renmin Hospital of Wuhan University
- Received National Natural Science Foundation grant, Key R&D Program sub-project from the Ministry of Science and Technology
Publications
- Bevacizumab improves survival in metastatic colorectal cancer patients with primary tumor resection: A meta-analysis, Cao D, Zheng Y, Xu H, Ge W, Xu X, 2019
- Hepatitis B virus X protein-induced SH2 domain-containing 5 (SH2D5) expression promotes hepatoma cell growth via an SH2D5-transketolase interaction, Zheng Y, Ming P, Zhu C, Si Y, Xu S, Chen A, Wang J, Zhang B, 2019
- The landscape of DNA methylation in hepatocellular carcinoma, Zheng YF, Lu X, Zhang XY, Guan BG, 2019
- LINC01133 aggravates the progression of hepatocellular carcinoma by activating the PI3K/AKT pathway, Zheng YF, Zhang XY, Bu YZ, 2019
- Immune checkpoint inhibitors in non-small-cell lung cancer: current status and future directions, Yan YF, Zheng YF, Ming PP, Deng XX, Ge W, Wu YG, 2019
- The extracellular vesicles secreted by lung cancer cells in radiation therapy promote endothelial cell angiogenesis by transferring miR-23a, Zheng Y, Liu L, Chen C, Ming P, Huang Q, Li C, Cao D, Xu X, Ge W, 2017
Awards
- 2014: Third Prize of Hubei Province Science and Technology for 'Mechanism and Clinical Application of Recombinant Human Endostatin Increasing Radiation Sensitivity'